Express Pharma

Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK + BLU-U Data for skin cancer treatment

Analyses of long-term data confirm that the continued and clinically meaningful results of ODOMZO (sonidegib) in people with locally advanced basal cell carcinoma (laBCC) are not impacted by concomitant medicines.

0 925

Sun Pharmaceutical Industries announced that one of its wholly-owned subsidiaries presented data analyses for two of its speciality medi